Cloning and immune characterization of the c-type lysozyme gene in red-spotted grouper, Epinephelus akaara

Fish and Shellfish Immunology

Volumn 36, Issue 1, 2014, Pages 305-314

  Mai, Weijun ^a   Liu, Peng ^a   Chen, Huiqing ^a   Zhou, Yajing ^a  

^a JIANGSU UNIVERSITY   (China)

Author keywords

Antimicrobial activity; C Type lysozyme; Cytokines; Epinephelus akaara; NF B pathway

Indexed keywords

EPINEPHELUS AKAARA; EPINEPHELUS ANALOGUS; ESCHERICHIA COLI; NEGIBACTERIA; POSIBACTERIA; VIBRIO ALGINOLYTICUS;

CYTOKINE; LYSOZYME; RECOMBINANT PROTEIN; RNA;

AMINO ACID SEQUENCE; ANIMAL; ANIMAL DISEASE; ANTIMICROBIAL ACTIVITY; ARTICLE; C-TYPE LYSOZYME; CHEMISTRY; DNA SEQUENCE; EPINEPHELUS AKAARA; FISH DISEASE; GENETICS; IMMUNOLOGY; IRIDOVIRUS; MICROBIOLOGY; MOLECULAR CLONING; MOLECULAR GENETICS; NF-ΚB PATHWAY; NUCLEOTIDE SEQUENCE; PERCIFORMES; PHAGOCYTOSIS; PHYLOGENY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; VIBRIO; VIBRIOSIS;

ANTIMICROBIAL ACTIVITY; C-TYPE LYSOZYME; CYTOKINES; EPINEPHELUS AKAARA; NF-ΚB PATHWAY;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CLONING, MOLECULAR; FISH DISEASES; IRIDOVIRUS; MOLECULAR SEQUENCE DATA; MURAMIDASE; PERCIFORMES; PHAGOCYTOSIS; PHYLOGENY; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; VIBRIO; VIBRIO INFECTIONS;

EID: 84891147681     PISSN: 10504648     EISSN: 10959947     Source Type: Journal    
DOI: 10.1016/j.fsi.2013.11.002     Document Type: Article

References (57)

1. Canfield R.E. The amino acid sequence of egg white lysozyme. JBiol Chem 1963, 238:2698-2707.
2. Simpson R.J., Begg G.S., Dorow D.S., Morgan F.J. Complete amino acid sequence of the goose-type lysozyme from the egg white of the black swan. Biochemistry 1980, 19:1814-1819.
3. Ito Y., Yoshikawa A., Hotani T., Fukuda S., Sugimura K., Imoto T. Amino acid sequences of lysozymes newly purified from invertebrates imply wide distribution of a novel class in the lysozyme family. Eur J Biochem 1999, 259:456-461.
4. Lysozymes: model enzymes in biochemistry and biology 1996, 25-120. Birkhǎuser Verlag, Basel. P. Jollès (Ed.).
5. Hikima J., Hirono I., Aoki T. Characterization and expression of c-type lysozyme cDNA from Japanese flounder (Paralichthys olivaceus). Mol Marine Biol Biotechnol 1997, 6(4):339.
6. Jiménez-Cantizano R.M., Infante C., Martin-Antonio B., Ponce M., Hachero I., Navas J.I., et al. Molecular characterization, phylogeny, and expression of c-type and g-type lysozymes in brill (Scophthalmus rhombus). Fish Shellfish Immunol 2008, 25(1):57-65.
7. Ye X., Zhang L., Tian Y., Tan A., Bai J., Li S. Identification and expression analysis of the g-type and c-type lysozymes in grass carp (Ctenopharyngodon idellus). Dev Comp Immunol 2010, 34(5):501-509.
8. Wei S., Huang Y., Cai J., Huang X., Fu J., Qin Q. Molecular cloning and characterization of c-type lysozyme gene in orange-spotted grouper (Epinephelus coioides). Fish Shellfish Immunol 2012, 33(2):186-196.
9. Harikrishnan R., Kim J.S., Kim M.C., Balasundaram C., Heo M.S. Molecular characterization, phylogeny, and expression pattern of c-type lysozyme in kelp grouper (Epinephelus bruneus). Fish Shellfish Immunol 2011, 31(4):588-594.
10. Shimada T., Park B.G., Wolf A.J., Brikos C., Goodridge H.S., Becker C.A., et al. Staphylococcus aureus Evades lysozyme-based peptidoglycan digestion that links phagocytosis, inflammasome activation, and IL-1β secretion. Cell Host Microbe 2010, 7(1):38-49.
11. Yu L.P., Sun B.G., Li J., Sun L. Characterization of a c-type lysozyme of (Scophthalmus maximus): expression, activity, and antibacterial effect. Fish Shellfish Immunol 2013, 34(1):46-54.
12. Lee-Huang S., Huang P.L., Sun Y., Kung H.F., Blithe D.L., Chen H.C. Lysozyme and RNases as anti-HIV components in beta-core preparations of human chorionic gonadotropin. Proc Natl Acad Sci U S A 1999, 96:2678-2681.
13. Kokoshis P.L., Williams D.L., Cook J.A., Di Luzio N.R. Increased resistance to Staphylococcus aureus infection and enhancement in serum lysozyme activity by glucan. Science 1978, 199:1340-1342.
14. Sava G., Ceschia V., Zabucchi G. Evidence for host-mediated antitumor effects of lysozyme in mice bearing the MCa mammary carcinoma. Eur J Cancer Clin Oncol 1988, 24:1737-1743.
15. Nagasawa K., Cruz-Lacierda E.R. Diseases of cultured groupers 2004, Southeast Asian Fisheries Development Center, Aquaculture Department, Iloilo, Philippines.
16. Lu D.Q., Bei J.X., Feng L.N., Zhang Y., Liu X.C., Wang L., et al. Interleukin-1β gene in orange-spotted grouper, Epinephelus coioides: molecular cloning, expression, biological activities and signal transduction. Mol Immunol 2008, 45(4):857-867.
17. Wei Y.C., Pan T.S., Chang M.X., Huang B., Xu Z., Luo T.R., et al. Cloning and expression of Toll-like receptors 1 and 2 from a teleost fish, the orange-spotted grouper (Epinephelus coioides). Vet Immunol Immunopathol 2011, 141(3):173-182.
18. Lam F.W.S., Wu S.Y., Lin S.J., Lin C.C., Chen Y.M., Wang H.C., et al. The expression of two novel orange-spotted grouper (Epinephelus coioides) TNF genes in peripheral blood leukocytes, various organs, and fish larvae. Fish Shellfish Immunol 2011, 30(2):618-629.
19. Guo M., Wei J., Huang X., Huang Y., Qin Q. Antiviral effects of β-defensin derived from orange-spotted grouper (Epinephelus coioides). Fish Shellfish Immunol 2012, 32(5):828-838.
20. Ding S.X., Zhang Z.W., Du J.Y., Wang J., Zeng H.S., Wang Y., et al. The cloning and polymorphism of MHC class II B gene from Epinephelus akaara. Acta Oceanol Sin 2009, 31:129-138.
21. Thompson J.D., Higgins D.G., Gibson T.J. Clustal W: improving the sensitivity of progressive multiple sequence weighting, position-specific gap penalties and weight metric choices. Nucleic Acids Res 1997, 22:4673-4680.
22. Nicholas K.B., Nicholas H.B. GENEDOC: a tool for editing and annotating multiple sequence alignments 1997, 14. Distributed by the author.
23. Kumar S., Tamura K., Nei M. MEGA3: integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief Bioinformatics 2004, 5(2):150-163.
24. Shugar D. The measurement of lysozyme activity and the ultra-violet inactivation of interferon. Biochem Biophys Acta 1952, 8:302-309.
25. Osserman E.F., Lawlor D.P. Serum and urinary lysozyme (muramidase) in monocytes and monomyelocytic leukemia. JExp Med 1966, 124:921-952.
26. Correa R.G., Tergaonkar V., Ng J.K., Dubova I., Izpisua-Belmonte J.C., Verma I.M. Characterization of NF-κΒ/IκΒ proteins in zebra fish and their involvement in notochord development. Mol Cell Biol 2004, 24:5257-5268.
27. Nitta K., Sugai S. The evolution of lysozyme and α-lactalbumin. Eur J Biochem 1989, 182:111-118.
28. Ting K.L., Jernigan R.L. Identifying a folding nucleus for the lysozyme/α-lactalbumin family from sequence conservation clusters. JMol Evol 2002, 54:425-436.
29. Vocadlo D.J., Davies G.J., Laine R., Withers S.G. Catalysis by hen egg-white lysozyme proceeds via a covalent intermediate. Nature 2001, 412:835-838.
30. Kato S., Okamura M., Shimamoto N., Utiyama H. Spectra evidence for a rapidly formed structural intermediate in the refolding kinetics of hen egg-white lysozyme. Biochemistry 1981, 20:1080-1085.
31. Thunnissen A.M., Isaacs N.W., Dijkstra B.W. The catalytic domain of a bacterial lytic transglycosylase defines a novel class of lysozymes. Proteins 1995, 22:245-258.
32. Nilsen I.W., Myrnes B., Edvardsen R.B., Chourrout D. Urochordates carry multiple genes for goose-type lysozyme and no genes for chicken- or invertebrate-type lysozymes. Cell Mol Life Sci 2003, 60:2210-2218.
33. Grütter M.G., Weaver L.H., Matthews B.W. Goose lysozyme structure: an evolutionary link between hen and bacteriophage lysozymes?. Nature 1983, 303:828-831.
34. Paulsen S.M., Lunde H., Engstad R.E., Robertsen B. Invivo effects of β-glucan and LPS on regulation of lysozyme activity and mRNA expression in Atlantic salmon (Salmo salar). Fish Shellfish Immunol 2003, 14(1):39-54.
35. Saurabh S., Sahoo P.K. Lysozyme: an important defence molecule of fish innate immune system. Aquac Res 2008, 39(3):223-239.
36. Krieg N.R., Gerhardt P. Solid, liquid/solid, and semisolid culture. Am Soc Microbiol 1994, 32:216-223.
37. Gao F.Y., Qu L., Yu S.G., Ye X., Tian Y.Y., Zhang L.L., et al. Identification and expression analysis of three c-type lysozymes in (Oreochromis aureus). Fish Shellfish Immunol 2012, 32(5):779-788.
38. Hikima S., Hikima J., Rojtinnakorn J., Hirono I., Aoki T. Characterization and function of kuruma grouper lysozyme possessing lytic activity against Vibrio species. Gene 2003, 316:187-195.
39. Siwicki A.K., Morand M., Klein P., Kiczka W. Treatment of infectious pancreatic necrosis virus (IPNV) disease using dimerized lysozyme (KLP-602). JAppl Ichthyol 1998, 14:229-232.
40. Mai W.J., Wang W.N. Protection of blue shrimp (Litopenaeus stylirostris) against the white spot syndrome virus (WSSV) when injected with shrimp lysozyme. Fish Shellfish Immunol 2010, 28(4):727-733.
41. Siwicki A.K., Klein P., Morand M., Kiczka W., Studnicka M. immunostimulatory effects of dimerized lysozyme (KLP-602) on the nonspecific defense mechanisms and protection against furunculosis in salmonids. Vet Immunol Immunopathol 1998, 61:369-378.
42. Hancock R.E., Scott M.G. The role of antimicrobial peptides in animal defenses. Proc Natl Acad Sci U S A 2000, 97(16):8856-8861.
43. Kadowaki T., Yasui Y., Nishimiya O., Takahashi Y., Kohchi C., Soma G.I., et al. Orally administered LPS enhance head kidney macrophage activation with down-regulation of IL-6 in common carp (Cyprinus carpio). Fish Shellfish Immunol 2013, 34:1569-1575.
44. Lewis C.E., McCarthy S.P., Lorenzen J., McGee J.O. Differential effects of LPS, IFN-gamma and TNF alpha on the secretion of lysozyme by individual human mononuclear phagocytes: relationship to cell maturity. Immunology 1990, 69(3):402.
45. Hong S., Peddie S., Campos-Pérez J.J., Zou J., Secombes C.J. The effect of intraperitoneally administered recombinant IL-1β on immune parameters and resistance to Aeromonas salmonicida in the rainbow trout (Oncorhynchus mykiss). Dev Comp Immunol 2003, 27(9):801-812.
46. Berger M., Wetzler E.M., Wallis R.S. Tumor necrosis factor is the major monocyte product that increases complement receptor expression on mature human neutrophils. Blood 1988, 71:151-158.
47. Nair M.P., Mahajan S., Reynolds J.L., Aalinkeel R., Nair H., Schwartz S.A., et al. The flavonoid quercetin inhibits proinflammatory cytokine (tumor necrosis factor alpha) gene expression in normal peripheral blood mononuclear cells via modulation of the NF-kappa beta system. Clin Vaccine Immunol 2006, 13:319-328.
48. Aldieri E., Atragene D., Bergandi L., Riganti C., Costamagna C., Bosia A., et al. Artemisinin inhibits inducible nitric oxide synthase and nuclear factor NF-kB activation. FEBS Lett 2003, 552(2):141-144.
49. Phi V.L. Transcriptional activation of the chicken lysozyme gene by NF-kappa Bp65 (RelA) and c-Rel, but not by NF-kappa Bp50. Biochem J 1996, 313:39-44.
50. Zhao Y., Joshi-Barve S., Barve S., Chen L.H. Eicosapentaenoic acid prevents LPS-induced TNF-α expression by preventing NF-κB activation. JAm Coll Nutr 2004, 23(1):71-78.
51. Shames B.D., Selzman C.H., Pulido E.J., Meng X., Meldrum D.R., McIntyre R.C., et al. LPS-induced NF-κB activation and TNF-α release in human monocytes are protein tyrosine kinase dependent and protein kinase C independent. JSurg Res 1999, 83(1):69-74.
52. Sharif O., Bolshakov V.N., Raines S., Newham P., Perkins N.D. Transcriptional profiling of the LPS induced NF-κB response in macrophages. BMC Immunol 2007, 8(1):1.
53. Carter A.B., Monick M.M., Hunninghake G.W. Lipopolysaccharide-induced NF-κB activation and cytokine release in human alveolar macrophages is PKC-independent and TK-and PC-PLC-dependent. Am J Respir Cell Mol Biol 1998, 18(3):384-391.
54. Lu Y.C., Yeh W.C., Ohashi P.S. LPS/TLR4 signal transduction pathway. Cytokines 2008, 42(2):145-151.
55. Gatto M.T., Falcocchio S., Grippa E., Mazzanti G., Battinelli L., Nicolosi G., et al. Antimicrobial and anti-lipase activity of quercetin and its C2-C16 3-O-acyl-esters. Bioorg Med Chem 2002, 10(2):269-272.
56. Dhingra V., Pakki S.R., Narasu M.L. Antimicrobial activity of artemisinin and its precursors. Curr Sci 2000, 78(6):709-713.
57. Comalada M., Camuesco D., Sierra S., Ballester I., Xaus J., Gálvez J., et al. Invivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappaB pathway. Eur J Immunol 2005, 35(2):584-592.